| November 25, 2015 | ISSUE NUMBER 27 VOL 1 |
Regulatory
FDA Slow to Update Sponsor Communications Policies
After months of anticipation, pharmaceutical marketers and the Washington legal community continue to wait for FDA to address options for updating its policies governing sponsor communications involving unapproved drug uses
...Read more |
| |
 |
| |
Agencies
The ‘Prosolidate’ Push: New Agency Service Mix
Higher risks have emerged in network relationships due to three recent industry forces: the rising cost of procurement, the maturation of digital, and the growing complexity of pharmaceutical products and their marketing needs. To mitigate the risks, pharma marketers are supplementing their network relationships with specialized talent, untethered innovation, and leading-edge capabilities from out-of-network sources
...Read more |
| |
Free White Paper “Hiding in Plain Sight: Copay as the Key to Patient Engagement.” How is our changing healthcare landscape influencing patient affordability programs? Go beyond traditional approaches and see how Pharma is defining program success in the new value-based healthcare landscape.
 Learn more
|
| |
Special Feature
Pharm Exec's 2016 Pipeline Report
Falling enterprise values and the drug pricing controversy have defined the life sciences landscape during the waning days of 2015. Will a pipeline harvest full of treatments founded on strong science, supportive regulation, and unmet medical need offer solace to shareholders and the promise of a reputational rebound?
...Read more |
Digital Health
New Directions in eHealth
PharmExec speaks to Donato Tramuto about how companies like Physicians Interactive are facilitating the interaction between physicians and pharma in the digital age, and to ascertain what he sees as the key trends shaping the immediate future of e-health
...Read more |
Digital Integration
Streamlining the Delivery of Compliant Promotional Content
By implementing integrated content compliance and digital asset management solutions into marketing workflows, life sciences companies can maximize the time and resources, writes David Bennett.
...Read more |
|
 |
 //Atlas Genetics (Bath, UK) announced the appointment of Keith Stauffer as VP Sales and Marketing. Based in the newly opened Boston, MA, office, Keith will lead the launch and commercialization of the Atlas Genetics io system.//BioNJ, the trade association for New Jersey's life sciences industry, announced that Randi Bromberg joined the organization as Vice President, Communications and Marketing.//Astellas (Northbrook, IL) announced the appointment of Dr. Peter Sandor as Vice President, Head of Oncology Therapeutic Area in Marketing Strategy.//Paragon Bioservices (Baltimore, MD) hired Kevin Sly as Senior Vice President Marketing & Commercial Strategy.// |
|
| |
 |
December 2–3: Publication Planning
Philadelphia, PA
January 28–29, 2016: 11th Summit on Biosimilars
Alexandria, VA
February 23–24, 2016: Oncology Commercialization and Market Access
San Francisco, CA.
|
|
|
|
